Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Spring is here, but forecasts say the temperature change will be ‘slow’

March 20, 2026

A ‘lone actor’ attack on Jewish Canadians is ‘realistic’ risk: report

March 20, 2026

Could GLP-1 drugs help your mental health? New study finds a link

March 20, 2026

Taylor Frankie Paul’s ex asks for sole custody of child, files protective order

March 20, 2026

Mission Success: Rocket Lab Launches Latest Satellite for Synspective

March 20, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » ESTEE SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Estee To Contact Him Directly To Discuss Their Options
Press Release

ESTEE SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Estee To Contact Him Directly To Discuss Their Options

By News RoomDecember 27, 20233 Mins Read
ESTEE SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding 0,000 In Estee To Contact Him Directly To Discuss Their Options
Share
Facebook Twitter LinkedIn Pinterest Email

If you suffered losses exceeding $100,000 investing in Estee stock or options between August 18, 2022 and May 2, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/EL.

There is no cost or obligation to you.


NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Estée Lauder Companies Inc. (“Estee” or the “Company”) (NYSE: EL) and reminds investors of the February 5, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: defendants misled investors with unrealistic and materially false statements about market demand Estee’s products and its inventory levels. These statements concealed the truth about Estee’s weakness in the market until, on May 3, 2023, Estee announced weaker sales and profit for the year than estimated and accordingly cut its fiscal year outlook for a third consecutive time. As a result, the price of Estee stock declined from $245.22 per share on May 2, 2023 to $202.70 per share on May 3, 2023.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Estee’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6e8a581f-1c68-4596-885c-0a64b18c9ae1

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Mission Success: Rocket Lab Launches Latest Satellite for Synspective

Memory Lift Safeness Issues Arise: Do NOT Buy from Third-Party Retail Websites to Avoid Side Effects Risk

CityPlace Welcomes Moxies as New Social Dining Destination

Yanik Guillemette Warns of “Innovation Crisis” as Bill C-22 Threatens Canada’s Digital Economy and Global Competitiveness

Jelly Lean (URGENT REPORT 2026) Is It Legit? Benefits, Ingredients, Official Website, Complaints, and Customer Feedback

TRACE ASI Launches Advanced Market Analysis Platform Powered by Artificial Intelligence

Sugar Harmony: The TRUTH Behind the “5-Drop Morning Hack” and Hidden Ingredient Dangers

All California University of Science and Medicine MD Graduates Receive Residency Placements during Match Day 2026

Accolad: The Employee Recognition Platform Revolutionizing HR Programs in Canada

Editors Picks

A ‘lone actor’ attack on Jewish Canadians is ‘realistic’ risk: report

March 20, 2026

Could GLP-1 drugs help your mental health? New study finds a link

March 20, 2026

Taylor Frankie Paul’s ex asks for sole custody of child, files protective order

March 20, 2026

Mission Success: Rocket Lab Launches Latest Satellite for Synspective

March 20, 2026

Latest News

Microsoft is ending the Windows Update nightmare — and letting you pause them indefinitely

March 20, 2026

Memory Lift Safeness Issues Arise: Do NOT Buy from Third-Party Retail Websites to Avoid Side Effects Risk

March 20, 2026

CityPlace Welcomes Moxies as New Social Dining Destination

March 20, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version